(Q41748484)

8 October 2017

title

In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine (English)

1 reference

8 October 2017

K Y Hostetler

1

1 reference

8 October 2017

J L Hammond

2

1 reference

8 October 2017

G D Kini

3

1 reference

8 October 2017

S E Hostetler

4

1 reference

8 October 2017

J R Beadle

5

1 reference

8 October 2017

K A Aldern

6

1 reference

8 October 2017

T C Chou

7

1 reference

8 October 2017

D D Richman

8

1 reference

8 October 2017

J W Mellors

9

1 reference

8 October 2017

publication date

1 May 2000

1 reference

Antiviral Chemistry & Chemotherapy

8 October 2017

published in

1 reference

8 October 2017

volume

11

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

213-219

1 reference

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Foscarnet for suppression of human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Membrane-Interactive Phospholipids Inhibit HIV Type 1-Induced Cell Fusion and Surface gp160/gp120 Binding to Monoclonal Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Novel Membrane-Interactive Ether Lipid Analogs That Inhibit Infectious HIV-1 Production and Induce Defective Virus Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100304

10.1177/095632020001100304

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference